Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2020

DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2020
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2020
The figures have not been audited

Attachments

DBB Bursa Report Q3 2020.pdf
268.5 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2020

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2020
30 Sep 2019
30 Sep 2020
30 Sep 2019
$$'000
$$'000
$$'000
$$'000
1 Revenue
133,772
142,855
435,816
438,707
2 Profit/(loss) before tax
18,568
19,768
55,686
56,870
3 Profit/(loss) for the period
14,127
14,859
42,417
43,240
4 Profit/(loss) attributable to ordinary equity holders of the parent
14,127
14,859
42,417
43,240
5 Basic earnings/(loss) per share (Subunit)
2.03
2.20
6.16
6.49
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.50
1.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.8400
0.7700

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 12 Nov 2020
Category Financial Results
Reference Number FRA-01112020-00001